Epidermal Growth Factor Receptor Protein Detection in Head and Neck Cancer Patients: A Many-Faceted Picture
β Scribed by Thariat, J.; Etienne-Grimaldi, M.-C.; Grall, D.; Bensadoun, R.-J.; Cayre, A.; Penault-Llorca, F.; Veracini, L.; Francoual, M.; Formento, J.-L.; Dassonville, O.; De Raucourt, D.; Geoffrois, L.; Giraud, P.; Racadot, S.; Moriniere, S.; Milano, G.; Van Obberghen-Schilling, E.
- Book ID
- 121702362
- Publisher
- American Association for Cancer Research
- Year
- 2012
- Tongue
- English
- Weight
- 711 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1078-0432
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The epidermal growth factor receptor (EGFR) has been shown to be a promising therapeutic target in head and neck cancer. Cetuximab, a monoclonal antibody against EGFR, has been approved in the United States for use with radiotherapy for head and neck squamous cell carcinoma. However, th
## Background: Over-expression of human epidermal growth factor receptor (egfr) is associated with a variety of human malignancies, including head and neck cancer. it has also been studied for its effect on cancer cell responses to chemotherapy. to accurately measure changes in egfr expression that